1. Home
  2. MYO vs NKTR Comparison

MYO vs NKTR Comparison

Compare MYO & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYO
  • NKTR
  • Stock Information
  • Founded
  • MYO 2004
  • NKTR 1990
  • Country
  • MYO United States
  • NKTR United States
  • Employees
  • MYO N/A
  • NKTR N/A
  • Industry
  • MYO Industrial Specialties
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYO Health Care
  • NKTR Health Care
  • Exchange
  • MYO Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • MYO 153.0M
  • NKTR 160.4M
  • IPO Year
  • MYO 2017
  • NKTR 1994
  • Fundamental
  • Price
  • MYO $3.22
  • NKTR $0.59
  • Analyst Decision
  • MYO Strong Buy
  • NKTR Strong Buy
  • Analyst Count
  • MYO 4
  • NKTR 6
  • Target Price
  • MYO $9.50
  • NKTR $4.92
  • AVG Volume (30 Days)
  • MYO 477.7K
  • NKTR 2.3M
  • Earning Date
  • MYO 05-07-2025
  • NKTR 05-08-2025
  • Dividend Yield
  • MYO N/A
  • NKTR N/A
  • EPS Growth
  • MYO N/A
  • NKTR N/A
  • EPS
  • MYO N/A
  • NKTR N/A
  • Revenue
  • MYO $38,628,624.00
  • NKTR $87,248,000.00
  • Revenue This Year
  • MYO $57.44
  • NKTR N/A
  • Revenue Next Year
  • MYO $21.76
  • NKTR N/A
  • P/E Ratio
  • MYO N/A
  • NKTR N/A
  • Revenue Growth
  • MYO 97.60
  • NKTR N/A
  • 52 Week Low
  • MYO $2.76
  • NKTR $0.43
  • 52 Week High
  • MYO $7.17
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • MYO 26.65
  • NKTR 39.04
  • Support Level
  • MYO $4.65
  • NKTR $0.57
  • Resistance Level
  • MYO $4.87
  • NKTR $0.81
  • Average True Range (ATR)
  • MYO 0.28
  • NKTR 0.06
  • MACD
  • MYO -0.11
  • NKTR -0.01
  • Stochastic Oscillator
  • MYO 3.28
  • NKTR 7.48

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: